Agenda

The detailed programme will be published soon...

Day 1

Wednesday 14 October 2026

11:00

IPOPI Bus departure

from Van der Valk Congrès Liège Hotel to the MECC Congress Venue in Maastricht

11:50

Registration & Lunch

at Exhibition Area


13:00

Session 1: Welcome Session

Moderator: Martine Pergent

IPOPI Room: Brussels&Paris room - Level 0

13:00 – 13:15 IPOPI’s Welcome by Martine Pergent, IPOPI President

13:15 – 13:20 SAS Welcome to Maastricht by Sian van den Bogaerdt and Janine Bastiaans, SAS (NMO the Netherlands)

13:20 – 14:00
• Andrea Gressani Keynote lecture: What is new in gastrointestinal condition & treatment? by Prof Charlotte Cunningham-Rundles (USA)

• Q&A 

14:00 – 15:15
Workshop: the PID/SID ecosystem – Patient-centredness – Patient choice by Martine Pergent, IPOPI President and Miriam Ferreira, NMO Programmes Manager
(Workshop sponsored by Takeda)

15:15

Coffee Break

Praetorium – Patio next to our room (Level 0)

15:45

Session 2: Respiratory Health Challenges and Advancing Patient-Centered Research

IPOPI Room: Brussels&Paris room - Level 0

15:45 – 16:15 (Part 1) Keynote lecture: Respiratory health challenges by Prof Hélène Salvator (France)

16:15 – 17:05 (Part 2) How to get involved in patient-centred research by Dimas Adhi Sugiharto and Lúcia Mamede

• Impact of patient organisations on research by Prof Frank Staal (The Netherlands)

• Understanding research, clinical trials and patient outcomes by Dr Maartje Blom (the Netherlands)

 • Put your research knowledge to the test by Whitney Ayoub, IPOPI Board Member, and Lúcia Mamede, IPOPI Medical Affairs Project Manager 

• Q&A 

17:15

Congress joint opening ceremony

ESID – INGID-IPOPI ceremony

Plennary 1/South Hall - Level 1

17:40

Session 3 – The NMO marketplace

Praetorium (Patio next to our room) - Level 0

17:40 – 19:00 Showcase of NMO projects and achievements

19:00

Welcome Reception

19:45

IPOPI Bus departure

 from Congress Venue to Van der Valk Congrès Liège Hotel 

(registration mandatory)

Day 2

Thursday 15 October 2026

08:00

Bus departure

from Van der Valk Congrès Liège Hotel to the MECC Congress Venue in Maastricht 

(registration mandatory)

09:00

Session 4 – Access

Moderator: Roberta Anido

IPOPI Room: Brussels&Paris room - Level 0

09:00 – 09:15 Spotlight: “PID-Experts programme” by Janine Bastiaans, SAS (NMO the Netherlands)

09:15 – 10:30 Navigating early access – empowering the PID community Contents 
(Workshop sponsored by Savara)

• The journey of a medicine by Leire Solis, IPOPI Health Policy and Advocacy Director

• What existing early access regulatory schemes by Gabriela Cuervo, Early Access Consultant, Savara

• Hospital exemption by Dr Alessandra Magnani (Spain)

• Workshop on the “role of NMOs in…” 

    - The process of setting up a research programme by Dr Marlène Pasquet (France) and Cynthia Olotch, IPOPI Board Member, Kenya

    - Medicine assessment by Leire Solis and David Jiménez, AEDIP (NMO Spain) 

    - Medicine coverage by Vivian Kohlberg (NMO Bolivia) and Bruce Lim, IPOPI Vice-President (Malaysia)

    - Access to treatment abroad by Dr Bénédict Neven (France) and Otilia Stanga, IPOPI Treasurer (Romania)

    - Pharmacovigilance by Anne-Sophie Henry-Eude (NMO France) and Roberta Anido, IPOPI Board Member (Argentina)

    - Clinical trial by Dr Maria Pia Cicalese (Italy) and Tracy Shaw, IPOPI Board Member (USA)

 10:30 - 11:15 Worldwide Plasma – Personalised medicine

• Latest updates in immunoglobulins: IgA and IgM by Prof Martin van Hagen, IPOPI MAP Vice-Chair

• Plasma and geopolitics by Matthew Hotcko, Marketing Research Bureau

• IPOPI’s positioning on plasma by Johan Prévot, IPOPI Executive Director

• NMO example on working to improve plasma collection by Juçaíra Giusti, ELPIB (NMO Brazil)

• Q&A

11:15

Coffee Break

Praetorium – Patio next to our room (Level 0)

11:45

Session 5 – Physical and mental health

Moderator: Otilia Stanga

IPOPI Room: Brussels&Paris room - Level 0

11:45 – 12:15 (Part 1) The power of data 

• Collecting the right data for the right purpose by Leire Solis, IPOPI Health Policy and Advocacy Director

• Registry case: the upcoming ASID registry by Dr Diana Marangu-Boore (Kenya) 

• NMO Case Study: Member Database by Maria Löfving Sonesson, PIO (NMO Sweden)

• Q&A

12:15 – 13:00 (Part 2) Mental health care(s) in PIDs! (Joint IPOPI-ESID-INGID session) by Otilia Stanga, Fabio Candotti and Rosalind Fischer

• The patient's perspective by Bruce Lim, IPOPI Board Member

• The physician's perspective by Dr Anne de Pagter, ESID

• The nurse's perspective by Julia Hews-Girard, PhD, RN, INGID

• Panel discussion

13:00

Lunch Break

Exhibition Area (Expo Foyer - Level 1)

IPOPI Group picture (Praetorium Patio next to our room - Level 0)


14:00

Session 6 – Economic Challenges in Immunodeficiency: Diagnosis, Testing, and Care

Moderator: Bruce Lim

IPOPI Room: Brussels&Paris room - Level 0

14:00 – 15:15
Economic and patient outcomes impact/cost of delayed and misdiagnosis for PIDs and SIDs 
(Workshop sponsored by CSL Behring)

• Consequences of late and misdiagnosis on PIDs by Prof Isabelle Meyts (Belgium)

• Consequences of late and misdiagnosis on SIDs by Prof Stephen Jolles (United Kingdom)

• Economic impact of early diagnosis and treatment of IEIs: project in Spain by Prof Pere Soler Palacín (Spain)

• Understanding the broader value of immunoglobulin therapy in IEI - Insights from a French social return on investment analysis by Batyrkhan Kuatov, Director, Health Economics Outcome Research, CSL-Behring

• Q&A

• Assessing the national impact of delays and misdiagnoses in PIDs and SIDs by Martine Pergent, IPOPI President and Dimas Adhi Sugiharto, IPOPI Board Member

15:15 – 16:00 Genetic testing: access and economics

• Understanding genetic testing: What it is and the methods used by Dr Cybel Mehawej (Lebanon)

• Methods to implement genetic by Prof Jérémie Rosain (France)

• NMO case: What choice for NMOs who want to promote or financially support genetic testing nationally 

• Panel discussion

16:00

Coffee Break

Praetorium – Patio next to our room (Level 0)

16:30

Session 7 – MAP Speed-dating

16:30 – 17:30 The role of IPOPI’s Medical Advisory Panel (MAP) by Dr Nizar Mahlaoui, Prof Martin van Hagen and Prof Silvia Sánchez-Ramón

IPOPI MAP speed dating:

• Patient empowerment and shared decision-making by Prof Stuart Tangye (Australia); Dr Virgil Dalm (the Netherlands) and Dr Cecilia Poli (Chile)

• Immune dysregulation and associated conditions by Prof Tadej Avčin (Slovenia) and Dr Ciprian Jurcut (Romania)

• Genetic diagnosis by Prof Martin van Hagen (the Netherlands) and Prof Hirokazu Kanegane (Japan)

• AI in Health by Dr Nizar Mahlaoui (France) and Prof Isabelle Meyts (Belgium)

• Lifelong care for people living with PIDs by Prof Charlotte Cunningham-Rundles (USA) and Prof Silvia Sanchez-Ramon (Spain)

• Personalised therapies by Prof Klaus Warnatz (Germany), Prof Alain Fischer (France) and Prof Steven Holland (USA)

17:45

IPOPI Bus Departure

from Congress Venue to Van der Valk Congrès Liège Hotel  (registration mandatory)

19:00

IPOPI PID Champion Awards Dinner

(by invitation only with mandatory registration)

Day 3

Friday 16 October 2026

08:00

IPOPI Bus departure

from Van der Valk Congrès Liège Hotel to the MECC Congress Venue in Maastricht

09:00

Session 8 – PIDs & SIDs

Moderator: Tracy Shaw

IPOPI Room: Brussels&Paris room - Level 0

9:00 – 9:15 Spotlight: “The circle of support programme” by Carolyn Dews, IDFA (NMO Australia)

by 09:15 – 10:30
Update on SIDs / PIDs
(Sponsored by Grifols)  

• Introduce IPOPI’s position on PIDs/SIDs by Martine Pergent, IPOPI President

• Update on PIDs: a broader approach to the warning signs by Dr Jacques Rivière (Spain)

• Updates on SIDs – What connects them to PIDs? by Dr Virgil Dalm (the Netherlands)

• Testimonies from NMOs integrating SIDs into their mission by Andrea Maier-Neuner, DSAI (NMO Germany), Natalia Romeo, AAPIDP (NMO Argentina), Tracy Shaw, IDF (NMO USA).

• IPOPI resources by Tracy Shaw, IPOPI Board Member and Lúcia Mamede, IPOPI Medical Affairs Project Manager

• Q&A

10:30

Coffee Break

Praetorium – Patio next to our room (Level 0)

11:00

Session 9 – Annual General Meeting

Moderators: Martine Pergent and Johan Prévot

IPOPI Room: Brussels&Paris room - Level 0

11:00 – 12:00 IPOPI Annual General Meeting (open to IPOPI members only)

12:00

Session 10 – Advanced Therapies (Part 1)

Moderator: Cynthia Olotch

IPOPI Room: Brussels&Paris room - Level 0

12:00 – 12:45 

• Transplant: where are we? by Prof Despina Moshous, ESID President

• Transplant follow-up by Dr Reem Elfeky (Egypt/UK)

• Biotherapies, targeted therapies, bio-similars: Access & Management by Prof Klaus Warnatz (Germany)

• Q&A

12:45

Lunch Break

Exhibition Area (Expo Foyer - Level 1)

13:45

Session 11 – Advanced therapies (Part 2)

IPOPI Room: Brussels&Paris room - Level 0

13:45 – 14:30
Hot spots in the patient journey (Joint IPOPI-INGID session)

• Transition care/adult immunologists by Dr Nizar Mahlaoui, IPOPI MAP Chair

• Women and PIDs by Prof Siobhan Burns (United Kingdom) 

• PID in golden years by Sarita Workman, INGID Board Member

• Q&A

14:30 – 15:45
Gene Therapy: Development, Latest Advances, and Patient Perspective by Johan Prévot
(Educational Grant from Fondazione Telethon)

• Set the scene: Experience of a patient undergoing gene therapy

• ABC of gene therapy by Prof Alessandro Aiuti (Italy)

• Latest and future advances by Prof Claire Booth (UK)

• Just like home programme by Federico Fraschetta (Italy) 

• Q&A

• Panel discussion: What action to improve access? by Prof Alessandro Aiuti (Italy), Prof Claire Booth (the United Kingdom) and Johan Prévot, IPOPI Executive Director

15:45 – 16:00 Closure of the meeting by Martine Pergent

16:30

Bus departure for the IPOPI social activity

(by invitation only with mandatory registration)

17:00

Social Activity

Maastricht walking tour

(by invitation only with mandatory registration)

19:00

IPOPI Bus departure

From city center to Van der Valk Congrès Liège Hotel